Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin Pulse Regimen for Cluster Headache
NCT02981173Phase 1Completed
- Sponsor
- Yale University
- Start
- Dec 2016
- Primary completion
- Jun 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of psilocybin in Cluster Headache (CH) (3 arms), sponsored by Yale University. Primary endpoints: Time to first attack after completion of pulse regimen at 2 months, Time to last attack after completion of pulse regimen at 6 months and 4 more. Started Dec 2016; status: completed.
02
Drugs
psilocybin
03
Conditions
Cluster Headache (CH)
Beyond the preview
Go deeper on NCT02981173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02981173.